Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Aurinia Pharmaceuticals Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +15 vs. Q1 2023
- Shares held
- 50.3M
- −145.0K (−0.3%) vs. Q1 2023
- Total value
- $487.5M
- −$65.6M (−11.9%) vs. Q1 2023
- New holders
- 33
- 65 more added
- Sold out
- 18
- 50 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Trading LLC | 0 | $0 | 0.00% | −129,080−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −105,952−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −82,453−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −73,500−100.0% | Sold out |
| Innovis Asset Management LLC | 0 | $0 | 0.00% | −27,410−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Gladstone Institutional Advisory LLC | 0 | $0 | 0.00% | −17,300−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −14,469−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| XR Securities LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,586−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −8,740−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Accel Wealth Management | 0 | $0 | 0.00% | −1,045−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Savior LLC | 0 | $0 | 0.00% | −801−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −221−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Kula Investments, LLC | – | – | – | – | Not filed |